Congratulations! SPARK at Stanford Translational Research Program wins 2022 Pantheon Award from California Life SciencesRead More »
SPARK is honored to receive the 2020 Janet Davison Rowley Patient Impact Research Award!
In developing new drugs for rare diseases, this non-profit steps in when pharmaceutical companies won’t
A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain cancer drug, one that might have ended up overlooked by pharmaceutical companies.Read More »